Area of research
Oncology · Dermatology
Research interest
Research interests include Medicine, Lymphoma, Immunotherapy, Nivolumab, Internal medicine, and Oncology.
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Cytotoxic lymphoma assessment response (CLyAR): A harmonized, compartment-based consensus response assessment framework for cytotoxic T-cell lymphomas
Neoadjuvant relatlimab and nivolumab in resectable melanoma
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders
Severe de novo pustular psoriasiform immune‐related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma
Prognostic significance of acral lentiginous histologic type in T1 melanoma
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy